LEBWOHL, M.; STROBER, B.; LANGLEY, R. G.; OKUBO, Y. .; FOLEY, P.; WARREN, R.; PETERSON, L.; CROSS, N.; WIEGRATZ, S.; DEHERDER, D.; THAÇI, D. Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s305, 2024. DOI: 10.25251/skin.8.supp.305. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2451. Acesso em: 3 jul. 2024.